Allianz Asset Management Gmb H Adaptive Biotechnologies Corp Transaction History

Allianz Asset Management Gmb H

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $2.34 Million - $5.4 Million	-366,290 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $356,375 - $1.02 Million	-35,215 Reduced 8.77%	366,290 $5.08 Million
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $1.17 Million - $1.71 Million	-46,530 Reduced 10.39%	401,505 $11.3 Million
Q3 2021 Nov 10, 2021	SELL	$30.02 - $39.87 $531,173 - $705,459	-17,694 Reduced 3.8%	448,035 $15.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $13.1 Million - $18.1 Million	405,482 Added 673.03%	465,729 $19 Million
Q1 2021 May 13, 2021	SELL	$37.26 - $67.74 $13.1 Million - $23.8 Million	-351,887 Reduced 85.38%	60,247 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $4.75 Million - $6.91 Million	105,569 Added 34.44%	412,134 $24.4 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $2.18 Million - $2.97 Million	60,860 Added 24.77%	306,565 $14.9 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $5.6 Million - $10.9 Million	224,347 Added 1050.41%	245,705 $11.9 Million
Q1 2020 May 14, 2020	SELL	$16.96 - $34.16 $221,141 - $445,412	-13,039 Reduced 37.91%	21,358 $593,000
Q4 2019 Feb 13, 2020	SELL	$24.56 - $32.8 $691,953 - $924,107	-28,174 Reduced 45.03%	34,397 $1.03 Million
Q3 2019 Nov 13, 2019	SELL	$30.31 - $53.51 $4.28 Million - $7.56 Million	-141,234 Reduced 69.3%	62,571 $1.93 Million
Q2 2019 Aug 08, 2019	BUY	$40.3 - $48.3 $8.21 Million - $9.84 Million	203,805 New	203,805 $9.84 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.